Index
A
Albumin, 3, 64, 170, 216, 247, 254, 257, 277
Alginate, 37, 88, 110, 247, 260, 276, 291, 332
Aluminium oxide (alumina), 58
Amphotericin B (AmB), 188
Anti-angiogenesis, 213
Anticancer effects, 211
Anti-inflammatory effects, 210
Antimetastatic effects, 214
Antioxidants, 77, 208, 262, 277
Antituberculosis drug carriers,
alginate nanoparticles, 291
Arborols, 300
Auronafin, 328
Aza[60]fulleroids, 23
Aziridino[60]fullerene, 23
B
Bacillus amyloliquefaciens, 98
Benzophenone, 179
Bioavailability, 112, 203, 243, 279, 329
Biodegradable polymers, 169
Biopolymers, 3, 59, 241, 269
Biovalve, 193
Blood–brain barrier (BBB), 37, 254,
278, 285
Bone, 135, 138
allografts, 145
autografts, 144
grafting, 143
tissue engineering, 152
xenografts, 145
Buccal delivery systems, chitosan, 287
Budesonide, 178
C
Calcium phosphate, 154, 158, 174
NPs, 64
Cancer metastasis, 206, 208, 212, 214, 227
Cancer therapeutics, 203
Cancer therapy, chitosan, 289
Carbohydrates, 241, 244
circulation, 256
drug loading, 246
drug release, 249
stability, 252
Carbon nanofibers, 58
Carbon nanotubes (CNT), 1, 2, 14, 58, 310
Carboxymethylchitosan (CMCTS), 109
Casein, 98, 248, 252, 259
Cellulose, 1, 3, 34, 118, 152, 253, 260, 262,
271, 287
Ceramic NPs, 58
Cerium oxide (ceria), 58
Chemotherapy, 299
Chitin, 1, 34, 89, 273
Chitin deacetylases, 96
Chitosan, 1, 34, 62, 89, 135, 156, 169, 189,
272, 286
hollow nanospheres (HNPs), 115
N-maleated (NMC), 105
Chitosan-based luminescent/magnetic (CLM)
nanomaterials, 117
Chitosan–cyclodextrin, 111
Chitosan–DNA, 290
Chitosan-g-PEG, 103
Chitosan–(acrylic acid) magnetite, 113
Chitosan–PELA, 115
Chitosan–poly(acrylic acid) (PAAC) hollow
nanospheres, 114
343